Schedule

  • Day 01

    14 September, 2021

  • Day 02

    15 September, 2021

  • Day 03

    16 September, 2021

1:00PM
to
1:30pm
1:00PM - 1:20PM Riyadh Time (GMT+3)

Introduction to Riyadh Global Medical Biotechnology Summit 2021

Prof. Ahmed Alaskar

MD, FRCPC, FACP
Executive Director
King Abdullah International Medical Research Center

Introduction to Riyadh Global Medical Biotechnology Summit 2021

Chairman, Riyadh Global Medical Biotechnology Summit 2021
1:20PM - 1:30PM Riyadh Time (GMT+3)

Video

1:30PM
to
2:30pm
1:30PM - 2:30PM Riyadh Time (GMT+3)

Sir Menelas N. Pangalos

Executive Vice President & President BioPharmaceutical R&D, AstraZeneca

Keynote Presentation: Developing a COVID-19 vaccine for the world at an unprecedented pace

Moderated by: Mr. Walter Klemp, CEO Moleculin, Inc.
2:30pm
to
4:00pm
2:30PM - 3:30PM Riyadh Time (GMT+3)

Round Table Discussion: Biotechnology in the Kingdom of Saudi Arabia: Challenges and Opportunities - Towards better Alignment with the Saudi National Vision 2030

Prof. Ahmed Alaskar

MD, FRCPC, FACP
Executive Director
King Abdullah International Medical Research Center

Eng. Suliman Almazroua

CEO of the National Industrial Development and Logistics Program

Eng. Nizar Al-Hariri

Chief Executive Officer
National Industrial Development Center

Dr. Ashraf Allam

CEO of the Pharmaceutical Investment Company (PIC)




DR. Abdulrahman Alnuaim

MD, FRCPC, FACP, CPE
Professor, Physician, healthcare executive and pharmaceutical industry Consultant at Ministry of Indsutry

DR. Pierre J. Magistrett

Director
KAUST Smart Health Initiative

Dr. Elie Haddad

Senior Advisor & Project Lead
Riyadh Biotech City
Royal Commission for Riyadh City (RCRC)

Dr. Malak AlThagafi

Director of the General Directorate for the National RDI
King Abdulaziz City for Science and Technology
3:30PM - 4:00PM Riyadh Time (GMT+3)

Break

4:00pm
to
6:00PM
4:00PM - 4:20PM Riyadh Time (GMT+3)

Dr. Horst Domdey

Chief Executive Officer
Biotech Cluster Development GmbH

The Munich Biotech Cluster: Turning Science into Innovation

4:20PM - 4:40PM Riyadh Time (GMT+3)

Dr. Mehmood Khan

Chief Executive Officer
Hevolution Foundation

Medical Biotechnology as a strategic pillar for KSA Health and Economic Development

4:40PM - 5:00PM Riyadh Time (GMT+3)

Dr. Richard Smith

Chief Operating Officer
Rockland Immunochemicals, Inc. USA

Driving Biotech Success with Agile Entrepreneurs

5:00PM - 5:20PM Riyadh Time (GMT+3)

Dr. Manal Alaamery

Head, Developmental Medicine, Chairman Innovation and Entrepreneurship KAIMRC, KSAU-HS, MNG-HA

Innovation and Intellectual Property at KAIMRC/KSAU-HS/MNG-HA

5:20PM - 5:40PM Riyadh Time (GMT+3)

Mr. Walter Klemp

Chairman and CEO
Moleculin Biotech, Inc.

Structuring Incentives to Drive Biomedical Sector Growth

5:40PM - 6:00PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Abdelali Haoudi

Head R&D Strategy and Business Development
Managing Director, Medical Biotechnology Park

Dr. Klaus Kleinfeld

Senior Advisor
Ministry of Industry, KSA



Dr. Horst Domdey

Chief Executive Officer
Biotech Cluster Development GmbH

Dr. Mehmood Khan

Chief Executive Officer
Hevolution Foundation

Dr. Richard Smith

Chief Operating Officer
Rockland Immunochemicals, Inc. USA

Dr. Manal Alaamery

Head, Developmental Medicine, Chairman Innovation and Entrepreneurship KAIMRC, KSAU-HS, MNG-HA

Mr. Walter Klemp

Chairman and CEO
Moleculin Biotech, Inc.
7:00pm
to
8:00pm
8:00PM
to
10:00pm
8:00PM - 8:20PM Riyadh Time (GMT+3)

Dr. Paul Rothmann

Chief Executive Officer
Johns Hopkins University, USA

A Joint Journey into the Future: How Biotech and Academic Research
Institutions Can Work Together to Foster Innovation

8:20PM - 8:40PM Riyadh Time (GMT+3)

Dr. Ronald DePinho

Professor and Past President
MD Anderson Cancer Center

Sporos Bioventures: A new model for biotech creation and development

8:40PM - 9:00PM Riyadh Time
(GMT+3)

Mr. Brady Huggett

Business Editor
Nature BiotechnologyNature Biotechnology

How Bioentrepreneurship Works

9:00PM - 9:20PM Riyadh Time (GMT+3)

Dr. Eric Kmiec

Founder and Director
The Gene Editing Institute
Helen F. Graham Cancer Center & Research Institute
Christiana Care Health System

The Gene Editing Institute at ChristianaCare; an innovation accelerator in a regional healthcare system 

9:20PM - 9:40PM Riyadh Time (GMT+3)

Dr. Hitesh Sanganee

Executive Director & Head of Emerging Innovations
AstraZeneca

Open Innovation and Entrepreneurship

9:40PM - 10:00PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Ronald DePinho

Professor and Past President
MD Anderson Cancer Center

Dr. Paul Rothmann

Chief Executive Officer
Johns Hopkins University, USA

Mr. Brady Huggett

Business Editor
Nature Biotechnology



Dr. Eric Kmiec

Founder and Director
The Gene Editing Institute
Helen F. Graham Cancer Center & Research Institute
Christiana Care Health System

Dr. Hitesh Sanganee

Executive Director & Head of Emerging Innovations
AstraZeneca
1:30pm
to
2:30pm
1:30PM - 2:30PM Riyadh Time (GMT+3)

Dr. Philip Larsen

Senior Vice President & Head Global R&D, BAYER AG

Keynote Presentation
Biotechnological advances in cardiovascular disease management: from a one to a billion

Moderated by: Mr. Markus Peterseim
2:30pm
to
5:00pm
2:30PM - 2:50PM Riyadh Time (GMT+3)

Dr. Majed Al Jeraisy

Chairman, Research Office
Director, Clinical Trial Services
KAIMRC

Biotechnology and Clinical Trials; Adding More Complexity or Facilitating?

2:50PM - 3:10PM Riyadh Time (GMT+3)

Dr. Ali Al Qarni

Head, KAIMRC- Eastern Region
Deputy Executive Regional Director-Medical Services, MNGHA

Real World Evidence in the Era of Digital Health: Opportunities and Challenges

3:10PM - 3:30PM Riyadh Time (GMT+3)

Dr. Rifat Atun

Professor Global Health Systems
Director of Global Health Systems Cluster
Harvard University, USA

Creating an ecosystem to harness digital and biotech innovations for precision health

3:30PM - 4:00PM Riyadh Time (GMT+3)

Break

4:00PM - 4:20PM Riyadh Time (GMT+3)

Dr. Lynda Chin

President and Chief Executive Officer
Apricity Health LLC, USA

Re-imagine Patient Access to expert cancer care in the Era of digital Medicine

4:20PM - 4:40PM Riyadh Time (GMT+3)

Dr. Ali Alessandro Ayach

Senior Director
Strategy and Performance Improvement
Alvarez & Marsal
Dubai, UAE

Acceleration clinical trials in the digital era and commercialization of outputs

4:40PM - 5:00PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Majed Al Jeraisy

Chairman, Research Office
Director, Clinical Trial Services
KAIMRC

Dr. Ali Al Qarni

Head, KAIMRC- Eastern Region
Deputy Executive Regional Director-Medical Services, MNGHA

Dr. Rifat Atun

Professor Global Health Systems
Director of Global Health Systems Cluster
Harvard University, USA

Dr. Lynda Chin

President and Chief Executive Officer
Apricity Health LLC, USA




Dr. Ali Alessandro Ayach

Senior Director
Strategy and Performance Improvement
Alvarez & Marsal
Dubai, UAE
5:00pm
to
7:10pm
5:00PM - 5:20PM Riyadh Time (GMT+3)

Dr. Hiep Tran

President and Chief Scientific Officer
Abzyme Therapeutics LLC
USA

Natural camelid single domain antibodies as potential alternatives to monoclonal antibodies in the next generation immunotherapy

5:20PM - 5:40PM Riyadh Time (GMT+3)

Dr. Joshua LaBaer

Executive Director
The Biodesign Institute

New Methods for Cell-Free Presentation of Proteins for Functional Analysis

5:40PM - 6:00PM Riyadh Time (GMT+3)

Dr. Fouad Atouf

Vice President, Global Biologics
US Pharmacopea, USA

Developing Cell and Gene Therapies: Challenges and Opportunities

6:00PM - 6:20PM Riyadh Time (GMT+3)

Mr. Markus Peterseim

Managing Director
Alvarez & Marsal
Frankfurt, Germany

Creating a Biosimilars and Biotherapeutics CDMO Hub

6:20PM - 6:40PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Joshua LaBaer

Executive Director
The Biodesign Institute

Dr. Hiep Tran

President and Chief Scientific Officer
Abzyme Therapeutics LLC
USA

Dr. Fouad Atouf

Vice President, Global Biologics
US Pharmacopea, USA



Mr. Markus Peterseim

Managing Director
Alvarez & Marsal
Frankfurt, Germany

Dr. Waldemar Radziszewski

Executive Medical Director
Global Clinical Development
AMGEN
6:40PM - 7:10PM Riyadh Time (GMT+3)

Break

7:10pm
to
9:20pm
7:10PM - 7:30PM Riyadh Time (GMT+3)

Dr. Hani Al Hashmi

Senior Medical Affairs Director
Pfizer
KSA

Biotechnology in Vaccine Development

7:30PM - 7:50PM Riyadh Time (GMT+3)

Dr. Jamila Louahed

Vice President and Head
Global R&D
GSK

Innovation in Vaccines

7:50PM - 8:10PM Riyadh Time (GMT+3)

Dr. Naif Al Harbi

Director, Vaccine Development Unit
Director, Research Quality Management
Research Scientist, Infectious Diseases Research Department
KAIMRC

Vaccine R&D in KSA: Experience and challenges

8:10PM - 8:30PM Riyadh Time (GMT+3)

Dr. Jon Heinrichs

Associate Vice President and Franchise Head
Sanofi Pasteur

RSV Prevention for All Infants and Children

8:30PM - 8:50PM Riyadh Time (GMT+3)

Mr. Sven Frie

General Manager
Commercial Enterprise Solutions
Cytiva

Cytiva and Vaccine Bioprocessing

8:50PM - 9:20PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Jamila Louahed

Vice President and Head
Global R&D
GSK

Dr. Hani Al Hashmi

Senior Medical Affairs Director
Pfizer
KSA


Dr. Naif Al Harbi

Director, Vaccine Development Unit
Director, Research Quality Management
Research Scientist, Infectious Diseases Research Department
KAIMRC

Dr. Jon Heinrichs

Associate Vice President and Franchise Head
Sanofi Pasteur

Mr. Sven Frie

General Manager
Commercial Enterprise Solutions
Cytiva
1:30pm
to
2:30pm
1:30PM - 2:30PM Riyadh Time (GMT+3)

Dr. Paolo Martini

Senior Vice President, Moderna

Keynote Presentation
Messenger RNA: a flexible platform for different therapeutic areas

Moderated by: Dr. Manal Alaamery
2:30pm
to
5:10pm
2:30PM - 2:50PM Riyadh Time (GMT+3)

Mr. Iain Sharp-Paul

Vice President EMEA Marketing
Cepheid

Mr. Sherif Harydi

General Manager
Middle East
Cepheid

Molecular diagnostics’ role in the fight against COVID and beyond

2:50PM - 3:10PM Riyadh Time (GMT+3)

Mr. Perry Frederick

Senior Director
Strategic Research
Europe, Middle East, and Africa
GE Healthcare

Oncology Care Pathway: Devices and Tracers

3:10PM - 3:30PM Riyadh Time (GMT+3)

Dr. Ahmed AlZahrani

Director of Healthcare Technology Development
Information Technology Department, MNGHA

MNGHA’s response to support the ventilator manufacturing initiatives by the local Small & Medium Enterprises (SMEs)

3:30PM - 3:50PM Riyadh Time (GMT+3)

Mr. Elie Chaillot

Vice-President and Chief Executive Officer
GE Healthcare, EMEA

Data and the Future of Healthcare in the COVID-19 Era

3:50PM - 4:10PM Riyadh Time (GMT+3)

Mr. Raymond Berglund

Managing Director & Head
Healthcare and Life Science
Alvarez & Marsal

What to consider in localization for manufacturing medtech/med devices – A pragmatic and accelerated approach

4:10PM - 4:40PM Riyadh Time (GMT+3)

Break

4:40PM - 5:10PM Riyadh Time (GMT+3)

Panel Discussion

Mrs. Bouchra Bensaoud

President
Danaher, Middle-East, Africa and Turkey

Mr. Raymond Berglund

Managing Director & Head
Healthcare and Life Science
Alvarez & Marsal

Mr. Iain sharp-Paul

Vice President EMEA Marketing
Cepheid

Mr .Sherif Harydi

General Manager
Middle East
Cepheid

Mr. Perry Frederick

Senior Director
Strategic Research
Europe, Middle East, and Africa
GE Healthcare

Dr. Ahmed AlZahrani

Director of Healthcare Technology Development
Information Technology Department, MNGHA

Mr. Elie Chaillot

Vice-President and Chief Executive Officer
GE Healthcare, EMEA
5:10pm
to
7:35pm
5:10PM - 5:30PM Riyadh Time (GMT+3)

Dr. Badr Al Ahmari

Director, Hematology Fellowship Program
Consultant, Adult Stem Cell Transplant and Cellular Therapy
Department of Oncology, KAMC
MNGHA - Riyadh

Chimeric Antigen Receptor T cells: lessons from B cell malignancies

5:30PM - 5:50PM Riyadh Time (GMT+3)

Dr. Joseph Fraietta

Director of the Solid Tumor Immunotherapy Laboratory
University of Pennsylvania (Philadelphia, PA)

Genetically Enhanced T Cells: Designing, Engineering, and Building Cancer Immunotherapies

5:50PM - 6:10PM Riyadh Time (GMT+3)

Dr. Khaled Al Sayegh

Associate Director, Biomedical Research
KAIMRC

Saudi Bank of Induced Pluripotent Stem Cells

6:10PM - 6:30PM Riyadh Time (GMT+3)

Dr. Amin Hajitou

Professor and Chair
Targeted Therapeutics
Imperial College London, UK

Development of the bacteria viruses, bacteriophage, into a delivery technology for therapeutic genes and DNA vaccines against cancer and other human diseases

6:30PM - 6:50PM Riyadh Time (GMT+3)

Dr. Miriam Fuchs

Global Therapeutic Area Lead, Cell and Gene Therapies, Oncology, Regulatory Affairs, Novartis 

The tisagenlecleucel (CAR-T) experience

6:50PM - 7:05PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Miriam Fuchs

Global Therapeutic Area Lead, Cell and Gene Therapies, Oncology, Regulatory Affairs, Novartis 

Dr. Badr Al Ahmari

Director, Hematology Fellowship Program
Consultant, Adult Stem Cell Transplant and Cellular Therapy
Department of Oncology, KAMC
MNGHA - Riyadh

Dr. Joseph Fraietta

Director of the Solid Tumor Immunotherapy Laboratory
University of Pennsylvania (Philadelphia, PA)

Dr. Khaled Al Sayegh

Associate Director, Biomedical Research
KAIMRC

Dr. Amin Hajitou

Professor and Chair
Targeted Therapeutics
Imperial College London, UK
7:05PM - 7:35PM Riyadh Time (GMT+3)

Break

7:35pm
to
10:05pm
7:35PM - 7:55PM Riyadh Time (GMT+3)

Prof. Majid Alfadhel

Deputy Executive Director
KAIMRC
Chairman, Genetics and Precision Medicine Department
King Abdulaziz Medical City

Genetic and Rare disease program(GARD): an opportunity for orphan diseases biotechnology

7:55PM - 8:15PM Riyadh Time (GMT+3)

Dr. Paolo Martini

Senior Vice President
Moderna

mRNA therapy for propionic acidemia: from bench to bedside

8:15PM - 8:35PM Riyadh Time (GMT+3)

Dr. Hicham Fenniri

Professor
Departments of Chemical Engineering
Bioengineering, Chemistry & Chemical Biology
Northeastern University, USA
& Chief Scientific Officer, MAScIR Foundation, Morocco

Magnetically Guided Rosette Nanotubes-siRNA Delivery for Cancer Gene Silencing

8:35PM - 8:55PM Riyadh Time (GMT+3)

Dr. Madhuri Hegde

Vice President and Chief Scientific Officer
PerkinElmer, Inc.

Beyond Exome: Whole Genome Sequencing for Rare Disease Diagnostics

8:55PM - 9:15PM Riyadh Time (GMT+3)

Prof. Majed Al Ghoribi

Chairman, infectious Diseases Research Department, Associate Research Scientist
King Abdullah International Medical Research Centre

Empowering Infectious Disease Surveillance using whole-genome sequencing

9:15PM - 9:35PM Riyadh Time (GMT+3)

Panel Discussion

Dr. Paolo Martini

Senior Vice President
Moderna

Prof. Majid Alfadhel

Deputy Executive Director
KAIMRC
Chairman, Genetics and Precision Medicine Department
King Abdulaziz Medical City

Dr. Hicham Fenniri

Professor
Departments of Chemical Engineering
Bioengineering, Chemistry & Chemical Biology
Northeastern University, USA
& Chief Scientific Officer, MAScIR Foundation, Morocco

Dr. Madhuri Hegde

Vice President and Chief Scientific Officer
PerkinElmer, Inc.

Dr. Majed Al Ghoribi

Chairman, infectious Diseases Research Department, Associate Research Scientist
King Abdullah International Medical Research Centre
9:35PM - 10:05PM Riyadh Time (GMT+3)

Summit Closing Remarks